Arteris (AIP) VP and General Counsel Alpern sells 12,502 shares, exercises options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Arteris, Inc. VP and General Counsel Paul L. Alpern reported option exercises and related share sales in Common Stock. On June 1, 2026, he sold 11,504 shares at a weighted average price of $35.9848 and 998 shares at a weighted average price of $36.3895 in open-market transactions, totaling 12,502 shares sold.
These sales were made pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. On the same date, he exercised options for 4,000 shares at an exercise price of $0.5600 and 2,500 shares at an exercise price of $9.2800, acquiring 6,500 shares through derivative exercises.
Following the transactions, Alpern held 80,384 to 92,886 shares of Common Stock directly, depending on the specific line item, and retained 61,000 incentive stock options and 27,500 non-qualified stock options with expiration dates in 2029 and 2035, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 12,502 shares ($450,286)
Net Sell
6 txns
Insider
Alpern Paul L
Role
VP and General Counsel
Sold
12,502 shs ($450K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 4,000 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | -- |
| Exercise | Common Stock | 4,000 | $0.56 | $2K |
| Exercise | Common Stock | 2,500 | $9.28 | $23K |
| Sale | Common Stock | 11,504 | $35.9848 | $414K |
| Sale | Common Stock | 998 | $36.3895 | $36K |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 61,000 shares (Direct, null);
Non-Qualified Stock Option (right to buy) — 27,500 shares (Direct, null);
Common Stock — 90,386 shares (Direct, null)
Footnotes (1)
- Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.27 to $36.26 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.28 to $36.56 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Incentive stock option, 25% of the total shares vested on August 26, 2020; thereafter, 1/48th of the total shares vested monthly for 3 years, beginning on September 26, 2020. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Key Figures
Shares sold: 12,502 shares
Sale price (block 1): $35.9848 per share
Sale price (block 2): $36.3895 per share
+5 more
8 metrics
Shares sold
12,502 shares
Total common shares sold on June 1, 2026
Sale price (block 1)
$35.9848 per share
Weighted average price for 11,504 shares sold
Sale price (block 2)
$36.3895 per share
Weighted average price for 998 shares sold
Options exercised
6,500 shares
Common shares acquired via derivative exercises
Incentive option strike price
$0.5600 per share
Exercise price for 4,000-share incentive stock option
Non-qualified option strike price
$9.2800 per share
Exercise price for 2,500-share non-qualified option
Common shares held
80,384–92,886 shares
Direct common stock holdings after reported transactions
Options remaining
88,500 options
61,000 incentive and 27,500 non-qualified options remaining
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, Incentive stock option, Non-qualified stock options, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan that was adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
Incentive stock option financial
"Incentive stock option, 25% of the total shares vested on August 26, 2020"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
Non-qualified stock options financial
"Non-qualified stock options, vesting in 16 equal quarterly installments"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
FAQ
What insider transactions did Arteris (AIP) VP Paul L. Alpern report?
Paul L. Alpern reported selling 12,502 shares of Arteris common stock and exercising options for 6,500 shares. The sales were open-market transactions, while the acquisitions came from exercising incentive and non-qualified stock options on June 1, 2026.
What stock options did Paul L. Alpern exercise in Arteris (AIP)?
He exercised options for 4,000 shares at an exercise price of $0.5600 and 2,500 shares at an exercise price of $9.2800. These derivative exercises converted existing options into common shares on June 1, 2026.
Were Paul L. Alpern’s Arteris (AIP) stock sales pre-planned?
Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. Such plans pre-schedule trades, indicating the timing was not chosen opportunistically.
What are the key terms of Paul L. Alpern’s Arteris (AIP) stock options?
His incentive stock option vested 25% on August 26, 2020, then monthly over three years starting September 26, 2020. His non-qualified options vest in 16 equal quarterly installments, beginning April 1, 2025, providing a structured long-term equity incentive.